Back

Short- and long-term imeglimin treatment reduces metabolic syndrome-related diabetic cardiomyopathy

26 August 2017 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Chronic heart failure (CHF) Diastolic dysfunction ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mrs Marianne Lachaux

INSERM U1096, Rouen (France)

31 More presentations in this session

Presentation thumbnail
Doctor P. Kanagala (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Doctor M. Sandstedt (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Mr C. Galan (Madrid, ES)
Abstract
Presentation thumbnail
Assistant Professor D. Kim (Suwon, KR)
Abstract
Presentation thumbnail
Doctor G. Dolci (Arzignano, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Chronic heart failure (CHF)

The Event

Event poster

ESC Congress 2017

26 August 2017 11:00 CET
You may be interested in
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Histidine triad nucleotide-binding protein 2 deficiency induce myocardial glucose utilization disorder in mice
26 August 2023
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025
thumbnail
Congress Presentation
Relationships between metabolic syndrome and outcomes in dilated cardiomyopathy.
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources